Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

This study has been completed.
Sponsor:
Information provided by:
Encysive Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00080457
First received: April 1, 2004
Last updated: November 8, 2007
Last verified: November 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2005
  Estimated Primary Completion Date: No date given